XGN
Exagen Inc
8.70$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.8% | 29.6% | 26.4% | 65.0% | 73.8% | 92.0% | 90.0% | 91.3% | 84.2% | 84.0% | 81.6% | 84.3% | |
| 47.1% | 26.9% | 17.2% | 55.1% | 45.6% | 81.6% | 73.3% | 80.6% | 72.4% | 64.1% | 49.3% | 55.5% | |
| 47.1% | 26.9% | 17.2% | 55.1% | 45.6% | 81.6% | 73.3% | 80.6% | 72.4% | 64.1% | 49.3% | 55.5% | |
| 0.3% | – | – | 3.0% | 20.6% | 6.5% | 11.4% | 7.8% | 7.0% | 11.5% | 17.5% | 18.7% | |
| – | 0.0% | 0.0% | 2.7% | 3.5% | 1.6% | 1.5% | 0.9% | 2.1% | 5.0% | – | – | |
| 7.5% | 9.0% | 10.9% | 6.6% | 5.4% | 1.6% | 2.7% | 3.9% | 15.2% | – | – | – | |
| 33.5% | 32.1% | 37.6% | 27.0% | 19.1% | 6.2% | 7.0% | 4.5% | 0.0% | – | – | – | |
| 6.2% | 4.7% | 3.5% | 0.7% | 0.0% | 6.2% | 7.0% | 4.5% | – | – | – | – | |
| 97.3% | 182.0% | 251.7% | 122.7% | 123.3% | 37.0% | 46.6% | 31.2% | 50.8% | 60.1% | 78.7% | 69.9% | |
| 64.3% | 153.1% | 238.7% | 24.5% | 31.0% | 6.7% | 11.2% | 7.5% | 11.2% | 20.9% | 30.2% | 24.4% | |
| 54.2% | 108.0% | 177.1% | 0.1% | 0.3% | 0.3% | 0.4% | 0.5% | 2.2% | 2.2% | 3.8% | 5.2% | |
| 2.7% | 10.7% | 14.9% | 8.7% | 4.4% | 1.7% | 3.8% | 2.0% | 3.5% | 5.5% | 9.3% | 7.2% | |
| – | 0.0% | 0.0% | 92.2% | 85.2% | 29.3% | 34.0% | 22.3% | 33.4% | 33.8% | 44.4% | 38.4% | |
| 2.7% | -82.0% | -151.7% | -22.7% | -23.3% | 63.0% | 53.4% | 68.8% | 49.2% | 39.9% | 21.3% | 30.1% | |
| -451.6% | -520.5% | -741.5% | -724.1% | -528.1% | -186.4% | -231.3% | -168.6% | -296.4% | -490.3% | -658.6% | -541.7% | |
| 0.3% | 0.3% | 0.4% | 0.3% | 0.2% | 14.2% | 16.1% | 12.9% | 19.8% | 31.0% | 40.7% | 37.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.